Meet our Advisory Board

Stewart Abbot

Advisory Board

VP Translational Research, Fate Therapeutics

Prof Chas Bountra

Advisory Board

Chief Scientific Officer, Structural Genomics Consortium, University of Oxford

Kim Bure

Advisory Board

Global Director of Regenerative Medicine, Sartorius Stedim

Becky Buzzeo

Advisory Board

Global Director, Life Sciences, Thermo Fisher

David DiGiusto

Advisory Board

Executive Director, Stem Cell and Cellular Therapeutics Operations, Stanford Health Care and Stanford University School of Medicine

Steve Frost

Advisory Board

CEO, FrostIncluded, Executive Advisor, KPMG LLP and Fellow, Harvard Kennedy School.

Prof Jeff Karp

Advisory board

Associate Prof, Harvard University

Prof Evan Snyder

Advisory Board

Professor, Sanford-Burnham Medical Research Institute

Brock Reeve

Advisory Board

Executive Director, Harvard Stem Cell Institute

David Newble

Advisory Board

A Board level executive with over 15 years experience leading life sciences businesses.

Dr Paul Predki

Advisory Board

Dr. Paul Predki serves as Vice President for Molecular & Protein Biology R&D at Life Technologies

At IPAV we are always looking for fellow healthcare disrupters. If you’re passionate about healthcare translation and client value. If you wish to join us on this extraordinary professional and personal adventure, please contact us with your CV and a short personal definition of healthcare translation